Abstract
Transient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel involved in pain sensation and in a wide range of non-pain-related physiological and pathological conditions. The aim of the present study was to explore the effects of selected heavy metal cations on the function of TRPV1. The cations ranked in the following sequence of pore-blocking activity: Co2+ [half-maximal inhibitory concentration (IC50) = 13 μM] > Cd2+ (IC50 = 38 μM) > Ni2+ (IC50 = 62 μM) > Cu2+ (IC50 = 200 μM). Zn2+ proved to be a weak (IC50 = 27 μM) and only partial inhibitor of the channel function, whereas Mg2+, Mn2+ and La3+ did not exhibit any substantial effect. Co2+, the most potent channel blocker, was able not only to compete with Ca2+ but also to pass with it through the open channel of TRPV1. In response to heat activation or vanilloid treatment, Co2+ accumulation was verified in TRPV1-transfected cell lines and in the TRPV1+ dorsal root ganglion neurons. The inhibitory effect was also demonstrated in vivo. Co2+ applied together with vanilloid agonists attenuated the nocifensive eye wipe response in mice. Different rat TRPV1 pore point mutants (Y627W, N628W, D646N and E651W) were created that can validate the binding site of previously used channel blockers in agonist-evoked 45Ca2+ influx assays in cells expressing TRPV1. The IC50 of Co2+ on these point mutants were determined to be reasonably comparable to those on the wild type, which suggests that divalent cations passing through the TRPV1 channel use the same negatively charged amino acids as Ca2+.
Keywords: Heavy metals, Somatosensory system, Pain, Calcium channel, TRPV1, Cobalt
Introduction
Small-diameter sensory neurons in the peripheral nervous system (PNS) express the transient receptor potential/vanilloid receptor subtype 1 (TRPV1). Four identical subunits of this protein form a functional Ca2+ channel. Similarly to other transient receptor potential channel members, the TRPV1 channel belongs in the large superfamily of cation channels with six transmembrane (TM) segments. Following agonist-induced channel opening, a pore loop between segments TM5 and TM6 serves as a cation filter and entry site [1].
When endovanilloids are produced under various inflammatory conditions around the C and Aδ afferents of these PNS neurons, TRPV1 transmits a specific pain sensation to the brain [2–4]. Besides endovanilloids such as anandamide [5, 6], TRPV1 is activated by acids (pH < 6.3) and chemo-irritants such as the exovanilloid capsaicin (CAPS) or resiniferatoxin, a naturally occurring, ultrapotent CAPS analogue with excellent specificity for TRPV1 [2, 7–9]. Moreover, TRPV1 can integrate the effects of heat and vanilloids. The heat-sensing domain has been mapped to the C-terminal intracellular region [3, 9, 10].
The vanilloid binding site is localized between segments TM3 and TM4 of TRPV1 [5]. The pain signal, however, is generated by opening of the Ca2+ channel situated between domains TM5 and TM6 of four identical subunits [11, 12]. An acidic peptide motif in the pore loop region of TRPV1 (DXEXXEXXD) may serve as a docking site for positively charged ions and channel blockers [13]. However, our sequence comparison and previous in silico model-building efforts have not revealed any obvious homology to other divalent metal ion (M2+)-binding structures such as the EF-hand (DXDXDGXXDXXE) or the Excalibur (DXDXDXXXCE) [13].
Various studies have demonstrated that positively charged molecules can act as TRPV1 receptor channel blockers by plugging the pore. Ruthenium Red (RuRed) (a well-known, but non-specific TRPV1 pore blocker) [11], R4W2 (a positively charged hexapeptide) [14] and anti-calmodulins/antipsychotic tricyclics [13] have been shown to be able to bind to the DXEXXEXXD domain of TRPV1, whereby they block the movement of Ca2+ through the pore region.
We set out to assess the effects of various metal cations at different concentrations on the vanilloid -or heat-induced activity of the TRPV1 channel, focusing on the investigation of the most potent cations in vitro and in vivo. Moreover, in our experiments we aimed to shed light on the characteristics of the gating of the TRPV1 channel in order to improve the understanding of the structure and function of the TRPV1 pore region, which may lead to the development of potentially useful painkiller drugs that modulate the activity of this receptor.
Materials and Methods
Reagents
Stock solutions (200 mM) of CoCl2, NiCl2, ZnSO4, CdCl2, CuSO4, CaCl2, CoCl2 and LaCl3 were dissolved in water and diluted as required to the working concentrations. To avoid the precipitation of insoluble La(OH)3 and La(CO3)3, the formation of radiocolloids and the loss of La3+ by adsorption to container surfaces, LaCl3 solution was prepared fresh daily in polyethylene vials [15]. RuRed and capsazepine (CapZ; Sigma-Aldrich, St. Louis, MO) were dissolved in DMSO. CAPS was dissolved initially as a stock solution of 3 mM in 95 % ethanol. The peptide R4W2 was synthetized in our laboratories and then dissolved in water and used as a 25 mM stock solution. Amitriptyline (AMI), purchased from Sigma-Aldrich, was dissolved in water.
Plasmids
The C-terminally epsilon-tagged rat TRPV1ε plasmid construct was prepared in the metallothionein (pMTH) plasmid vector as described earlier [9]. To avoid cell loss through the Ca2+-excytotoxic mechanism that occurs when TRPV1 is overexpressed at 37 °C, only the basal activity of the pMTH promoter was used. The protein kinase C ε epitope tag allowed immunological detection of the TRPV1ε protein, as earlier described [16]. Mutants Y627W, N628W, D646N and E651W were kindly given by Dr. K. J. Swartz (National Institutes of Health, Bethesda, MD 20892, USA) [17] and subcloned into an EF-promoter-driven green fluorescent protein (EGFP)-tagging plasmid vector. The EGFP tag was used for visual determination of the transfection rate by flow cytofluorometry with a FACSCalibur instrument (Becton Dickinson, San Jose, CA, USA).
Cell Lines Expressing TRPV1 Ectopically
The HaCaT keratinocyte cell line was a kind gift of Prof. B. Farkas (Department of Dermatology, University of Cologne, Federal Republic of Germany) [18]. The COS-7 (CRL-1651) and BALB/c-3T3 (CCL-163) cell lines were obtained from ATCC. The 3T3 and HaCaT cell lines permanently expressing the rat TRPV1 channel were prepared as described earlier [19]. COS7 cells were transiently transfected with plasmid containing the sequence of the Y627W, N628W, D646N or E651W TRPV1 mutants or the wild-type TRPV1 channel, by using the Fugene transfection reagent (Roche, Mannheim, Germany). The transfection efficacy was determined by flow cytofluorometry.
Primary Dorsal Root Ganglion Cultures
Were prepared from E16 embryonic rats as reported earlier [9]. Briefly, dorsal root ganglions (DRGs) were dissected and then processed in Hank’s balanced salt buffer until plated in Dulbecco’s Modified Eagle Medium (DMEM). The DMEM contained 20 mM HEPES, pH 7.4, 7.5 % foetal bovine serum, 7.5 % horse serum, 5 mg/ml uridine supplemented with 2 mg/ml 5-fluoro-2′-deoxyuridine and 40 ng/ml nerve growth factor to inhibit cell division and to promote the differentiation of long neuronal processes, respectively. Cells were seeded on 25 mm glass coverslips.
Cobalt Histochemistry
Rat DRG cells attached to the coverslips were washed in buffer A (in millimolars: NaCl, 57.5; KCl, 5; MgCl2, 2; HEPES, 10; glucose, 12; sucrose, 139; pH 7.4) for 2 min, and then incubated at 37 °C for 10 min in Co2+-uptake solution (buffer A + 5 mM CoCl2) containing 20 μM CAPS. High (20 μM) capsaicin concentration is used in order to obtain a robust and easily detectable Co2+ signal. Following a brief wash in buffer A, the water-soluble Co2+ taken up by the cells was precipitated with 0.12 % ammonium polysulphide (Sigma-Aldrich) in buffer A, which resulted in the formation of dark, water-insoluble CoS in TRPV1+ cells. Cells were fixed in 4 % formaldehyde and mounted on glass slides, using Kaiser’s glycerol gelatine (Merck, Darmstadt, FRG). Cells were examined under a Nikon light microscope (Melville, NY, USA) and photographed with a SPOT RT-SE™ Digital Camera (Diagnostic Instruments). Pictures of the cells were analysed by means of ImageJ 1.45 s software (National Institutes of Health, USA), and the subsequent statistical analyses were performed with PRISM™ 3.01 software (GraphPad Software, Inc. San Diego, CA, USA).
Vanilloid-Induced 45Ca2+ Uptake
Vanilloid-induced 45Ca2+ transport was assayed in the HaCaT adherent cell lines ectopically expressing the C-terminally ε-tagged rat TRPV1 (3 × 104 cells/well) and Cos7 cells transiently transfected with rat TRPV1 mutants, seeded in poly-d lysine-coated 96-well plates. Immediately before the transport assay, the cells were washed three times with physiological saline solution at room temperature (20–25 °C). We had previously found that TRPV1-transformed cells functioned in the same manner at room temperature as at 30 °C (data not shown). 45Ca2+ uptake was performed for 10 min with 0.1 μCi 45Ca2+ as radioactive tracer in a final volume of 100 μl (1.8 μM). CAPS was diluted from a 3 mM ethanol stock solution to the indicated final concentrations. For the termination of 45Ca2+ uptake, cells were rapidly washed four additional times with 0.2 ml PBS solution, and then lysed in 80 μl/well RIPA buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 % Triton X-100, 0.5 % deoxycholate, 0.1 % SDS and 5 mM EDTA) for 30 min [8, 9, 20, 21]. Aliquots of the solubilised cell extracts were mixed with 120 μl SuperMiX and counted in a 96-well plate liquid scintillation counter (TopCount-NXT, Packard). To measure the effect of temperature on the TRPV1 function in the 45Ca2+-uptake assay, TRPV1/HaCaT cells were plated on six-well plates. 45Ca2+ uptake was evoked with 10 ml preheated buffer. The procedure was followed as described above.
After the measurement, the data were corrected for the basal activity of TRPV1 and normalized from zero to one, where zero denotes the counts per minute in TRPV1/HaCaT cells without CAPS and one denotes the counts per minute in TRPV1/HaCaT cells with CAPS. The results of three parallel measurements were averaged and evaluated with PRISM™ 3.01 software (GraphPad Software, Inc. San Diego, CA, USA). During curve fitting, the “Analyze/Nonlinear regression (curve fit)/Sigmoidal dose–response” menu of PRISM™ software was applied. The curve-fitting equation was: Y = Y min + (Y max − Y min)/(1 + 10(logEC50-X)), where X = logarithm of concentration and Y = the response.
Eye Wipe Tests
Eye wipe tests were performed on CD1 mice. A 100 μM CAPS solution, or a solution containing 100 μM CAPS and 1 mM CoCl2, or a solution containing 100 μM CAPS and 5 μM CapZ was dropped into the eye, and the number of defensive wiping movements was then counted.
Statistical Analysis
One-way ANOVA followed by Turkey’s post-tests was performed with GraphPad Prism version 3.01 software (GraphPad Software, Inc. San Diego, CA, USA).
Results
In the 45Ca2+ uptake assay, the EC50 of CAPS for wild-type TRPV1 was determined to be 0.0860 μM. Approximately 1 μM CAPS caused the full activation (EC100) of TRPV1 at pH 7.5. Channel blocker-screening assays were therefore carried out with 2 μM CAPS (an excess amount of agonist), which does not cause Ca2+ cytotoxicity during the 10-min incubation period. The interactions of the metal ions with TRPV1 were studied by using a vanilloid-induced 45Ca2+-uptake assay. Experiments were carried out on the TRPV1/HaCaT permanent indicator cell line. Channel opening was induced by CAPS in the presence of progressively increasing M2+ concentrations in the uptake solution. Incubation of the cells in uptake solutions containing both 45Ca2+ and Mg2+, Mn2+ or La3+ (data not shown) resulted in little or no effect, even at the highest concentration (4 mM), whereas Zn2+ proved to be a weak [half-maximal inhibitory concentrations (IC50) = 27 μM] and only partial inhibitor of the 2 μM CAPS-induced 45Ca2+ uptake. The other cations effectively blocked the vanilloid-induced Ca2+ entry into TRPV1/HaCaT cells, with the following sequence of potency: Co2+ (IC50 = 13 μM) > Cd2+ (IC50 = 38 μM) > Ni2+ (IC50 = 62 μM) > Cu2+ (IC50 = 200 μM; Fig. 1a).
To assess the effect of Co2+, the most potent TRPV1 inhibitor, on the heat-activated TRPV1 channels, the activity of TRPV1 was investigated in the presence either of 2 μM CAPS alone or of 2 μM CAPS + 250 μM Co2+, at both 37 and 42 °C. The negative control did not contain CAPS. In this assay, high temperature activated the TRPV1 channels and also increased the CAPS-evoked 45Ca2+ influx. Co2+ reduced both the heat and CAPS-induced 45Ca2+ influx (Fig. 1b).
To compare the potency of Co2+ with those of the other positively charged channel blockers, we measured the IC50 values of RuRed, AMI and R4W2, which are known to have a docking site in the pore loop of TRPV1. The inhibitor potentials of these pore blockers were measured via the CAPS-induced 45Ca2+ uptake. All of them inhibited CAPS-activated TRPV1, with the following IC50 values: RuRed = 1 μM, AMI = 20 μM and R4W2 = 100 μM (Fig. 1c).
For a better understanding of the inhibition kinetics of Co2+ on TRPV1, increasing concentrations of both Co2+ and CAPS were applied in the vanilloid-induced 45Ca2+-uptake assays. The Ca2+ uptake of TRPV1/HaCaT cells was inhibited by the simultaneous presence of Co2+ in a dose-dependent manner. However, increasing concentrations of Co2+ decreased only the maximal response of efficacy (E max) of Ca2+ entry; the affinity of CAPS for TRPV1 did not change. The inflection point in the CAPS dose–response curves in each of the Co2+ co-incubation studies was found at ∼0.08 μM (i.e. EC50), independently of the Co2+ concentration. The Co2+ inhibition patterns unequivocally indicated channel blocking kinetics (Fig. 2a).
By varying the concentrations of Co2+ and Ca2+ and measuring the radioactive 45Ca2+ influx, we assessed whether there was a competition between Co2+ and Ca2+. The effect of dilution on the amount of accumulated 45Ca2+ did not appear at extracellular cold Ca2+ concentrations below 1 mM (Fig. 1a), indicating that TRPV1+ cells accumulate Ca2+ very effectively from the extracellular space and collect them putatively into ER or mitochondria. Increasing cold Ca2+ concentration decreased the inhibitory effect of Co2+ (IC50 values in the presence of 0, 15.625, 31.25, 62.5 and 125 μM cold Ca2+: 7.944, 51.22, 72.69, 79.09 and 189.1 μM, respectively), showing that the effect of Co2+ on Ca2+ entry mainly depends on the competition for entry sites. These results suggest that the Co2+ entry through the TRPV1 channel is slower, and the Co2+ displacing the Ca2+ from the pore region of TRPV1 slows down or inhibits the Ca2+ uptake (Fig. 2b).
The prolonged agonist stimulation of TRPV1 has been reported to result in an increased permeability to larger cations [22] or small molecules [23], due to conformational changes in the open state of the TRPV1. Thus, we analysed the kinetics of the channel-blocking activity of Co2+ by employing different CAPS concentrations. An anticipated shift in the IC50 of Co2+ would be evidence supporting the idea that Co2+ entry depends on the TRPV1 open stages. We indeed observed a shift in the IC50 of Co2+, which decreased with increasing CAPS concentration (Fig. 2c). Consequently, increasing agonist concentration enhances the blocking ability of Co2+. To investigate this phenomenon, we plotted the IC50 values as a function of CAPS concentration. Curve-fitting analysis confirmed a strong interrelationship between IC50 and the CAPS dose applied (Fig. 2d), suggesting that the increased efficiency of inhibition correlates with the different open-state conformations of the TRPV1 channel.
We traced Co2+ upon vanilloid induction in sensory neuron cultures prepared from DRGs of rat embryos. To test Co2+-accumulation patterns, cells were co-incubated with 20 μM CAPS in Co2+-containing Ca2+-uptake medium, and the Co2+ was then localized by means of NH4S histochemistry. These experiments revealed that Co2+ not only competes with Ca2+ but also enters into the cytosol of specific PNS sensory neurons. Functionally responsive vanilloid-sensitive neurons (i.e. TRPV1+) exhibited dark-brown Co2+ precipitates inside the rounded neuronal bodies (Fig. 3e). As expected from previous studies, TRPV1 is endogenously expressed in approximately one third of the cultured neurons [24–27]. Without CAPS, no intracellular Co2+ accumulation was observed (data not shown). Similar experiments were carried out on rTRPV1/HaCaT and rTRPV1/3T3 cell lines. The accumulation of Co2+ was blocked by RuRed, a channel blocker of heat and vanilloid pain signalling. Moreover, the dose-dependent inhibition of the cellular entry of Co2+ was determined by the co-application of 5 μM CapZ, a long-known competitive antagonist of pungent vanilloids. After analysis of the photographs of the cells with the ImageJ program, statistical analysis of the data further confirmed our findings: the mean gray values of CAPS-exposed, CAPS-free and CapZ-exposed cells proved to be significantly different (CAPS without Co2+, 72.05 ± 12.38 (S.D.), n = 146; CAPS + Co2+, 124.4 ± 21.51 (S.D.), n = 111; CAPS + Co2+ + CapZ, 76.92 ± 22.21 (S.D.), n = 100; P values of the t tests: CAPS without Co2+ vs. CAPS + Co2+, P < 0.0001; CAPS + Co2+ vs. CAPS + Co2+ + CapZ, P < 0.0001; CAPS without Co2+ vs. CAPS + Co2+ + CapZ, P = 0.0290; Fig. 3). The gray values were measured on the negatives of the images: the darker the cells, the higher the gray values. Analysis of the pictures in Fig. 4, showing TRPV1-expressing HaCaT cells, resulted in the same outcome. Following ANOVA, the groups were compared by using t tests. Each t test except that involving CAPS without Co2+ vs. CAPS + Co2+ + 100 μM CapZ indicated a significant difference between the pairs of groups (P < 0.05; Fig. 4). No substantial staining could be observed on 3T3 cells (Fig. 5a–e). Statistical analysis of the gray values of the cells indicated no significant darkening in the absence of TRPV1 in the cell membrane.
In order to rule out the possibility that Co2+ can enter the cells through VGCCs, 3T3 cells were challenged with 50 mM extracellular KCl. These cells did not show any VGCC activity: the high extracellular KCl concentration-induced depolarization that opens the VGCC channels did not cause 45Ca2+ accumulation in the 45Ca2+ -uptake assay.
Moreover, the VGCC blocker nisoldipine did not decrease the CAPS-induced TRPV1-mediated 45Ca2+ accumulation (data not shown). No Co2+ staining was observed in the presence of 50 mM extracellular KCl (Fig. 5f–j). ANOVA indicated no significant differences among the groups (P = 0.9150). These results confirm that the CAPS-induced Ca2+ and Co2+ influx in TRPV1/3T3 cells is due exclusively to the TRPV1 channel activity.
Besides the in vitro demonstration of Co2+ antagonism, we further validated this Co2+ inhibition phenomenon in tests of eye wiping in response to pungent vanilloids [28]. Co2+ again decreased the frequency of vanilloid-evoked defending movements. Inhibition experiments with CapZ cross-validated and confirmed our earlier findings (Fig. 6a).
To validate that Co2+ inhibition is a consequence of competition with Ca2+ for M2+-chelating sites in the pore loop domain, we prepared several point mutants in this region of TRPV1, and determined the channel kinetics through 45Ca2+-uptake experiments in 3T3 cells expressing the mutant channels. Some of these mutants had been partially characterized earlier in the context of spider venom channel inhibitors [17], and these residues proved to have an important role in the binding of various previously tested channel blockers (RuRed, etc.). Mutated sites are illustrated schematically in Fig. 6b. The EC50 and EC100 values of mutant channels for CAPS were different from those of the wild type (D646N EC50 = 270 nM, E651W EC50 = 540 nM, N628W EC50 = 720 nM and Y627W EC50 = 820 nM), and the blocking effects of Co2+ and RuRed on TRPV1 mutants were therefore analysed with 4 μM CAPS. The neutralization of D646 reduced the sensitivity of TRPV1 to RuRed inhibition [11]. Our 45Ca2+-influx studies on TRPV1 point mutants revealed the following IC50 data for RuRed: IC50 (D646N) = 12.8 μM > IC50 (N628W) = 1.33 μM > IC50 (E651W) = 0.94 μM > IC50 (wild type) = 0.87 μM > IC50 (Y627W) = 0.26 μM (Fig. 6c), which findings correspond with published results [17]. Likewise, Co2+ inhibited the 4 μM CAPS-evoked 45Ca2+ influx in the D646N and E651W point mutants similarly as determined in the wild type. The neutralization of D646 caused no or only a minimal change in IC50. As compared with the wild type in this representative experiment, Co2+ sensitivity was slightly reduced in the D646N mutant (IC50 = 18.3 vs. 25.7 μM). The Y627W, N628W and E651W mutants displayed little or no difference relative to the wild type (IC50 = 18.6, 16.4 and 15.3 μM, respectively vs. 18.3 μM; Fig. 6d). Based on these findings, inhibition seems to be a consequence of competition with Ca2+ for M2+-chelating sites in the pore loop domain.
Discussion
Testing the effects of various metal cations on the vanilloid-induced activity of the TRPV1 channel, we demonstrated that Mg2+, Mn2+ or La3+ caused little or no decrease in channel activity, whereas Zn2+ proved to be a weak and only partial inhibitor of the 2 μM CAPS-induced 45Ca2+ uptake. The other cations effectively blocked the vanilloid-induced Ca2+ entry into TRPV1/HaCaT cells, with the following sequence of potency: Co2+ > Cd2+ > Ni2+ > Cu2+.
It was reported by Nilius et al. [29] that Co2+ reduced the inward Ca2+ current through ECaC1 (TRPV5), a close relative of TRPV1, sharing around 30 % homology with it. Fast and reversible recovery of the current upon washout of the inhibitor was detected during their experiments. Furthermore, they identified other M2+-s as effective inhibitors of the Ca2+ influx. Their results indicated the following overall blocking sequence: Pb2+ = Cu2+ = Gd3+ > Cd2+ > Zn2+ > La3+ > Co2+ > Fe2+ > > Fe3+. Zeng et al. found Cu2+ to be a potent inhibitor of the whole-cell current evoked by intracellular ADP-ribose through TRPM2, another member of the TRP group. The inhibitory effect of Cu2+ was irreversible, and occurred only if Cu2+ was administered in outside-out patches, suggesting that the action site is located extracellularly. The TRPM2 current was also blocked by Hg2+, Pb2+, Fe2+ and Se2+ [30].
In accord with the above-mentioned findings, we also observed ion influx-inhibitory effects of M2+-s on TRP channel. Depending on the TRP channel type, differences of the orders of blocking potency could be detected. Furthermore, the blocking effects of the individual cations could be reversible or irreversible, depending on the channel type. The three channels are close relatives and share high degree of sequence and structural homology with one another, which explains the similar responses to M2+-s. Having diverged from a common ancestor, TRP channels operate on uniform principles. However, during evolution TRP superfamily has evolved for various specialized functions. TRPV1 and TRPV5, for example, belong to different subgroups of the TRPV family; TRPV1–4 are non-ion-selective, whilst TRPV5–6 are highly Ca2+-selective. Hence, this functional adaptation may cause the differences in the M2+-evoked responses.
As concerns our own results, Co2+ reduced not only CAPS-induced but also heat-induced 45Ca2+ influx. When increasing concentrations of both Co2+ and CAPS were applied, the Co2+ inhibition patterns indicated channel-blocking kinetics. Our dose–response and Co2+ accumulation experiments revealed a competition for binding sites and a co-entry mechanism. We presume that Co2+ inhibits TRPV1 through its ability to bind to the ion selectivity filter of the channel: it passes through the ion channel much more slowly than Ca2+. Ca2+ entry is also slowed down by the binding of Co2+, which occupies the appropriate amino acid residues of the ion selectivity filter. This hypothesis seems to be further supported by the findings of Sajadi [31], who determined the stability constants of the 1:1 complexes formed between M2+ and l-tryptophan and other amino acids. The sequence obtained in the case of tryptophan was Ca2+ < Mg2+ < Mn2+ < Co2+ < Ni2+ < Cu2+ > Zn2+, which follows the Irving-Williams sequence [32]. The order of the stability constants was similar in the cases of methionine, alanine, leucine, valine and glycine. The amino acid sequence of the putative pore region is STSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGD (Q8NER1, UniProt), containing all the tested amino acids but valine. The stability constants formed between M2+ and tryptophan were Ca2+, 2.55 ± 0.08; Mg2+, 2.84 ± 0.08; Mn2+, 3.34 ± 0.05; Co2+, 4.34 ± 0.07; Ni2+, 5.31 ± 0.06; Cu2+, 8.05 ± 0.05 and Zn2+, 5.00 ± 0.08. The stability constants for Mg2+ and Mn2+ are close to that of Ca2+, so these ions can probably readily pass through the open channel of TRPV1. Co2+, Ni2+ and Cu2+ can be characterized by much higher complex-forming strength, elucidating the elevated TRPV1 blocking potency. Interestingly, for these three M2+-s, an unexpected relationship can be observed between the stability constant and the TRPV1 blocking potency. The stronger the bond, the weaker the TRPV1 inhibition potency is. The ionic radii (in picometres) of these cations are Ca2+, 100; Mg2+, 72; Mn2+, 67; Co2+, 65; Ni2+, 69; Cu2+, 73 and Zn2+, 74 [33]. Ca2+ is likely to have the ideal ionic radius and stability constant in its reactions with amino acids in order to be effectively passed along the carbonyl groups of the peptide backbone in the ion selectivity filter and the pore loop. Co2+ has a medium stability constant and the smallest ionic radius, which is probably not adequate for efficient transport. These two parameters seem to be equally involved in the proper ion influx. The stronger the M2+-amino acid complex and the smaller the ionic radius is, the more probable it is that M2+ will block the Ca2+ influx through the TRPV1 channel. As another interesting finding, in our experiments, Zn2+seemed to be only weak and partial inhibitor of the ion current. Its stability constant is almost as high as that of Co2+, suggesting a strong TRPV1-blocking ability, whereas its ionic radius is much larger than that of Co2+. Interestingly, the IC50 of Zn2+ is the second lowest exceeding only that of Co2+, but Zn2+ can achieve a decrease of merely 30 % of the maximal ion influx.
The TRPV1 channel is a non-selective cation channel, and still shows preference for Ca2+. The sequence of permeability is Ca2+ > Mg2+ > Na+ = K+ = Cs+ [3]. In addition to all these, TRPV1 also conducts protons [34]. Following prolonged exposure to agonists, TRPV1 becomes permeable even to larger organic cations, including dyes such as YO-PRO1 and FM1-43 [22] and a lidocaine derivative QX-314 [23]. Increasing agonist concentration enhances the blocking ability of Co2+, suggesting a correlation between the increased efficacy of inhibition and the different open-state conformations of the TRPV1 channel. Further experiments (involving patch-clamp recordings) would be needed to clarify the inhibitory effect of Co2+ on the fluxes of the other cations or molecules mentioned above. However, no channel blocker or antagonist of TRPV1 has been reported that is able to block the flux of only one specific ion, and antagonists seem to block all these influxes. For example, CapZ blocks the influxes of both Ca2+ and Na+ [35]. Overall, we presume that Co2+ can also block the ion currents mentioned above.
Before the exploration of TRPV1 protein, Co2+ histochemistry was a very useful tool for the identification of vanilloid-sensitive primary afferent neurons with C-and Aδ fibres after in vivo experiments. Co2+ uptake and the postmortem determination of Co2+ deposits quite accurately identified C-and Aδ afferents, the neuronal subset that can be activated by treatment with a vanilloid agonist, CAPS [36, 37]. Likewise, as previously documented in a subpopulation of pseudo-unipolar neurons [38], we have now demonstrated selective vanilloid-induced Co2+ accumulation in the cytosol of DRG primary cultures and TRPV1-transfected HaCaT and 3T3 cells. The accumulation of Co2+ could be blocked by RuRed or CapZ in a dose-dependent manner. The CAPS-induced Ca2+ and Co2+ influxes in TRPV1/3T3 cells proved to be due exclusively to the TRPV1 channel and not to VGCC activity.
Co2+ inhibited the pain-evoked defensive movements in eye wipe tests in response to pungent vanilloids. However, not only TRPV1 but also some other calcium channels of the sensory neurons, such as VGCCs, can be blocked by Co2+ [39]. VGCCs share structural homology with TRPV1 channel. The α1 subunit of voltage-gated calcium channels is organized in four homologous domains (I–IV), with six transmembrane segments (S1–S6) in each [40]. There is an additional region (H5) between S5 and S6, which forms a part of the pore region of the channel [41]. Within each H5 region, there exist conserved glutamate residues, significantly homologous to conventional EF-hand motifs [42], acting as the selectivity filter [43]. Mn2+, Ni2+ and Cd2+ in contrast with Co2+ are known to be stronger blockers of the VGCCs. Cu2+, Mn2+ and Co2+ blocked high-voltage activated currents conducted by Ba2+ with IC50 of 920, 58, and 65 μM, respectively [44, 45]. All of these ions exert their effects through high-affinity docking to the cation-binding site at the IIIS5–H5 pore region of the VACCs [46, 47]. Since Co2+ has higher IC50 for VGCCs (≈65 μM) than for TRPV1 (≈15 μM), we can conclude that decrease in the number of eye wipes might be due, at least partially, to an inhibitory effect of Co2+ on TRPV1.
Positively charged tricyclics, K/R-rich basic peptides and RuRed dock to the DXEXXEXXD motif at the channel orifice [13]. Although our point mutants overlap with the RuRed docking site [11, 14, 45], our point mutant studies suggest that Co2+ has a different binding site. Accordingly, the D646N point mutant, which is crucial for RuRed binding, does not change the kinetic parameters of Co2+ inhibition in cells ectopically expressing the D646N mutant TRPV1. We carried out vanilloid-induced 45Ca2+-uptake experiments with channel point mutants of TRPV1 in which the agonist binding site remained intact. Interestingly, no significantly decreased efficacy of Co2+ inhibition was found when 646aspartate was replaced by asparagine. Based on these results, Co2+ is supposed to evoke its effect at a different site on the pore loop region than RuRed, or to use the same negatively charged amino acids passing through the TRPV1 channel as Ca2+. This line of research on functional point mutants should be continued to determine whether Co2+ has a specific binding site on the channel orifice or not.
Most painkiller drugs are competitive agonists and target the CAPS-binding domain [48]. As the 646DLEFTENYD acidic tetrad sequence of the TRPV1 receptor is unique among Ca2+-binding proteins, this permits the design of painkillers targeting the channel orifice of TRPV1 and acting as channel blockers. A better understanding of the structural background and dynamics of the competition of Ca2+ with other M2+ for entry may result in the discovery of novel channel blocker painkillers. Furthermore, our data can contribute to a better understanding of the structures and functions of all TRP superfamily members. The specific effect of the selected M2+-s on the given ion channel pore region can serve as a valuable constraint during in silico modelling of the pore region. By comparing the different cation action profiles of pore regions, the model can be fine-tuned. The mechanism of Co2+-mediated inhibition provides screening for adjuvant therapeutics with higher selectivity than that of AMI, an approved drug currently used in clinical practice, but with only limited efficacy and with serious side effects.
Acknowledgments
The excellent technical assistance of Erzsébet Kusz in the preparation of the cell lines is acknowledged. This work was supported by grants from the National Office for Research and Technology (OMFB-01630; OMFB-01703, OMFB-01576/2006 and BAROSS_DA07-DA_TECH_07-2008-0043). TL was supported by a Postdoctoral Fellowship of the Zoltán Magyary Foundation. ZO was supported by Marie Curie European Re-integration Grant MC-IRG030854-PAINKILLER; Ányos Jedlik Program NKFP-1-00019/2005; GVOP-3.3.1-05/1.-2005-05-0057/3.0, and BAROSS_DA07-DA_TECH_07-2008-0028. CV was supported by grants from the National Office for Research and Technology (OM-00051/2005, OMFB-01575/2006, ERC_HU_09 3D_TRPV1 OMFB-01813/2009 and TÁMOP-4.2.1.B-09/1/KONV) and the Hungarian Ministry of Health (552/2006). GS and CV are grateful for the award of Bolyai Fellowships of the Hungarian Academy of Sciences. The authors would like to express their appreciation to our native speaker lector for proofreading the manuscript.
Footnotes
Authors László Pecze and Zoltán Winter contributed equally to this work.
References
- 1.Latorre R. Perspectives on TRP channel structure and the TRPA1 puzzle. J Gen Physiol. 2009;133(3):227–229. doi: 10.1085/jgp.200910199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Tender GC, Walbridge S, Olah Z, Karai L, Iadarola M, Oldfield EH, Lonser RR. Selective ablation of nociceptive neurons for elimination of hyperalgesia and neurogenic inflammation. J Neurosurg. 2005;102(3):522–525. doi: 10.3171/jns.2005.102.3.0522. [DOI] [PubMed] [Google Scholar]
- 3.Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997;389(6653):816–824. doi: 10.1038/39807. [DOI] [PubMed] [Google Scholar]
- 4.Naziroglu M, Dikici DM, Dursun S. Role of oxidative stress and Ca (2)(+) signaling on molecular pathways of neuropathic pain in diabetes: focus on TRP channels. Neurochem Res. 2012;37(10):2065–2075. doi: 10.1007/s11064-012-0850-x. [DOI] [PubMed] [Google Scholar]
- 5.Gavva NR, Klionsky L, Qu Y, Shi L, Tamir R, Edenson S, Zhang TJ, Viswanadhan VN, Toth A, Pearce LV, Vanderah TW, Porreca F, Blumberg PM, Lile J, Sun Y, Wild K, Louis JC, Treanor JJ. Molecular determinants of vanilloid sensitivity in TRPV1. J Biol Chem. 2004;279(19):20283–20295. doi: 10.1074/jbc.M312577200. [DOI] [PubMed] [Google Scholar]
- 6.Olah Z, Karai L, Iadarola MJ. Protein kinase C(alpha) is required for vanilloid receptor 1 activation. Evidence for multiple signaling pathways. J Biol Chem. 2002;277(38):35752–35759. doi: 10.1074/jbc.M201551200. [DOI] [PubMed] [Google Scholar]
- 7.Brown DC, Iadarola MJ, Perkowski SZ, Erin H, Shofer F, Laszlo KJ, Olah Z, Mannes AJ. Physiologic and antinociceptive effects of intrathecal resiniferatoxin in a canine bone cancer model. Anesthesiology. 2005;103(5):1052–1059. doi: 10.1097/00000542-200511000-00020. [DOI] [PubMed] [Google Scholar]
- 8.Karai L, Brown DC, Mannes AJ, Connelly ST, Brown J, Gandal M, Wellisch OM, Neubert JK, Olah Z, Iadarola MJ. Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J Clin Invest. 2004;113(9):1344–1352. doi: 10.1172/JCI20449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kedei N, Szabo T, Lile JD, Treanor JJ, Olah Z, Iadarola MJ, Blumberg PM. Analysis of the native quaternary structure of vanilloid receptor 1. J Biol Chem. 2001;276(30):28613–28619. doi: 10.1074/jbc.M103272200. [DOI] [PubMed] [Google Scholar]
- 10.Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 1998;21(3):531–543. doi: 10.1016/S0896-6273(00)80564-4. [DOI] [PubMed] [Google Scholar]
- 11.Garcia-Martinez C, Morenilla-Palao C, Planells-Cases R, Merino JM, Ferrer-Montiel A. Identification of an aspartic residue in the P-loop of the vanilloid receptor that modulates pore properties. J Biol Chem. 2000;275(42):32552–32558. doi: 10.1074/jbc.M002391200. [DOI] [PubMed] [Google Scholar]
- 12.Jara-Oseguera AN-PA, Szallasi A, Islas L, Rosenbaum T. Molecular mechanisms of TRPV1 channel activation. Open Pain J. 2010;3:68–81. [Google Scholar]
- 13.Olah Z, Josvay K, Pecze L, Letoha T, Babai N, Budai D, Otvos F, Szalma S, Vizler C. Anti-calmodulins and tricyclic adjuvants in pain therapy block the TRPV1 channel. PLoS One. 2007;2(6):e545. doi: 10.1371/journal.pone.0000545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Himmel HM, Kiss T, Borvendeg SJ, Gillen C, Illes P. The arginine-rich hexapeptide R4W2 is a stereoselective antagonist at the vanilloid receptor 1: a Ca2+ imaging study in adult rat dorsal root ganglion neurons. J Pharmacol Exp Ther. 2002;301(3):981–986. doi: 10.1124/jpet.301.3.981. [DOI] [PubMed] [Google Scholar]
- 15.Enyeart JJ, Xu L, Enyeart JA. Dual actions of lanthanides on ACTH-inhibited leak K(+) channels. Am J Physiol Endocrinol Metab. 2002;282(6):E1255–1266. doi: 10.1152/ajpendo.00478.2001. [DOI] [PubMed] [Google Scholar]
- 16.Olah Z, Lehel C, Jakab G, Anderson WB. A cloning and epsilon-epitope-tagging insert for the expression of polymerase chain reaction-generated cDNA fragments in Escherichia coli and mammalian cells. Anal Biochem. 1994;221(1):94–102. doi: 10.1006/abio.1994.1384. [DOI] [PubMed] [Google Scholar]
- 17.Kitaguchi T, Swartz KJ. An inhibitor of TRPV1 channels isolated from funnel Web spider venom. Biochemistry. 2005;44(47):15544–15549. doi: 10.1021/bi051494l. [DOI] [PubMed] [Google Scholar]
- 18.Farkas B, Bonnekoh B, Mahrle G. Repeated treatment with dithranol induces a tolerance reaction in keratinocytes in vitro. Arch Dermatol Res. 1991;283(5):337–341. doi: 10.1007/BF00376624. [DOI] [PubMed] [Google Scholar]
- 19.Pecze L, Szabo K, Szell M, Josvay K, Kaszas K, Kusz E, Letoha T, Prorok J, Koncz I, Toth A, Kemeny L, Vizler C, Olah Z. Human keratinocytes are vanilloid resistant. PLoS One. 2008;3(10):e3419. doi: 10.1371/journal.pone.0003419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Clapham DE, Montell C, Schultz G, Julius D. International Union of Pharmacology. XLIII. Compendium of voltage-gated ion channels: transient receptor potential channels. Pharmacol Rev. 2003;55(4):591–596. doi: 10.1124/pr.55.4.6. [DOI] [PubMed] [Google Scholar]
- 21.Marshall IC, Owen DE, Cripps TV, Davis JB, McNulty S, Smart D. Activation of vanilloid receptor 1 by resiniferatoxin mobilizes calcium from inositol 1, 4, 5-trisphosphate-sensitive stores. Br J Pharmacol. 2003;138(1):172–176. doi: 10.1038/sj.bjp.0705003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Chung MK, Guler AD, Caterina MJ. TRPV1 shows dynamic ionic selectivity during agonist stimulation. Nat Neurosci. 2008;11(5):555–564. doi: 10.1038/nn.2102. [DOI] [PubMed] [Google Scholar]
- 23.Binshtok AM, Bean BP, Woolf CJ. Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers. Nature. 2007;449(7162):607–610. doi: 10.1038/nature06191. [DOI] [PubMed] [Google Scholar]
- 24.Fernihough J, Gentry C, Bevan S, Winter J. Regulation of calcitonin gene-related peptide and TRPV1 in a rat model of osteoarthritis. Neurosci Lett. 2005;388(2):75–80. doi: 10.1016/j.neulet.2005.06.044. [DOI] [PubMed] [Google Scholar]
- 25.Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron. 2002;36(1):57–68. doi: 10.1016/S0896-6273(02)00908-X. [DOI] [PubMed] [Google Scholar]
- 26.Malin S, Molliver D, Christianson JA, Schwartz ES, Cornuet P, Albers KM, Davis BM. TRPV1 and TRPA1 function and modulation are target tissue dependent. J Neurosci. 2011;31(29):10516–10528. doi: 10.1523/JNEUROSCI.2992-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Zhang X, Huang J, McNaughton PA. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. Embo J. 2005;24(24):4211–4223. doi: 10.1038/sj.emboj.7600893. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Pecze L, Pelsoczi P, Kecskes M, Winter Z, Papp A, Kaszas K, Letoha T, Vizler C, Olah Z. Resiniferatoxin mediated ablation of TRPV1+ neurons removes TRPA1 as well. Can J Neurol Sci. 2009;36(2):234–241. doi: 10.1017/s0317167100006600. [DOI] [PubMed] [Google Scholar]
- 29.Nilius B, Prenen J, Vennekens R, Hoenderop JG, Bindels RJ, Droogmans G. Pharmacological modulation of monovalent cation currents through the epithelial Ca2+ channel ECaC1. Br J Pharmacol. 2001;134(3):453–462. doi: 10.1038/sj.bjp.0704272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Zeng B, Chen GL, Xu SZ. Divalent copper is a potent extracellular blocker for TRPM2 channel. Biochem Biophys Res Commun. 2012;424(2):279–284. doi: 10.1016/j.bbrc.2012.06.107. [DOI] [PubMed] [Google Scholar]
- 31.Sajadi SAA. Complex bilding behavior of l-tryptophan and related amino acids, a comparative investigation. Am J Chem. 2011;1(2):60–64. [Google Scholar]
- 32.Irving H, Williams RJP (1953) The stability of transition-metal complexes. J Chem Soc (637):3192–3210. doi:10.1039/JR9530003192
- 33.Shannon R. Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides. Acta Crystallogr A. 1976;32(5):751–767. doi: 10.1107/S0567739476001551. [DOI] [Google Scholar]
- 34.Vulcu SD, Liewald JF, Gillen C, Rupp J, Nawrath H. Proton conductance of human transient receptor potential-vanilloid type-1 expressed in oocytes of Xenopus laevis and in Chinese hamster ovary cells. Neuroscience. 2004;125(4):861–866. doi: 10.1016/j.neuroscience.2004.02.032. [DOI] [PubMed] [Google Scholar]
- 35.Grant ER, Dubin AE, Zhang SP, Zivin RA, Zhong Z. Simultaneous intracellular calcium and sodium flux imaging in human vanilloid receptor 1 (VR1)-transfected human embryonic kidney cells: a method to resolve ionic dependence of VR1-mediated cell death. J Pharmacol Exp Ther. 2002;300(1):9–17. doi: 10.1124/jpet.300.1.9. [DOI] [PubMed] [Google Scholar]
- 36.Hu-Tsai M, Winter J, Woolf CJ. Regional differences in the distribution of capsaicin-sensitive target-identified adult rat dorsal root ganglion neurons. Neurosci Lett. 1992;143(1–2):251–254. doi: 10.1016/0304-3940(92)90276-D. [DOI] [PubMed] [Google Scholar]
- 37.Winter J, Evison CJ, O’Brien C, Benowitz L, Lindsay RM, Mulderry P, Woolf C. Neurotoxic damage evokes regenerative responses from adult rat sensory neurones. Neurosci Lett. 1992;146(1):48–52. doi: 10.1016/0304-3940(92)90169-8. [DOI] [PubMed] [Google Scholar]
- 38.Reichling DB, Barratt L, Levine JD. Heat-induced cobalt entry: an assay for heat transduction in cultured rat dorsal root ganglion neurons. Neuroscience. 1997;77(2):291–294. doi: 10.1016/S0306-4522(96)00511-8. [DOI] [PubMed] [Google Scholar]
- 39.Nishimura T, Krier J, Akasu T. Effects of vasoactive intestinal contractor on voltage-activated Ca2+ currents in feline parasympathetic neurons. Am J Physiol. 1993;265(6.1):1158–1168. doi: 10.1152/ajpgi.1993.265.6.G1158. [DOI] [PubMed] [Google Scholar]
- 40.Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure–function relationships of voltage-gated calcium channels. Pharmacol Rev. 2005;57(4):411–425. doi: 10.1124/pr.57.4.5. [DOI] [PubMed] [Google Scholar]
- 41.Guy HR, Conti F. Pursuing the structure and function of voltage-gated channels. Trends Neurosci. 1990;13(6):201–206. doi: 10.1016/0166-2236(90)90160-C. [DOI] [PubMed] [Google Scholar]
- 42.Doughty SW, Blaney FE, Orlek BS, Richards WG. A molecular mechanism for toxin block in N-type calcium channels. Protein Eng. 1998;11(2):95–99. doi: 10.1093/protein/11.2.95. [DOI] [PubMed] [Google Scholar]
- 43.Mikala G, Bahinski A, Yatani A, Tang S, Schwartz A. Differential contribution by conserved glutamate residues to an ion-selectivity site in the L-type Ca2+ channel pore. Febs Lett. 1993;335(2):265–269. doi: 10.1016/0014-5793(93)80743-E. [DOI] [PubMed] [Google Scholar]
- 44.Castelli L, Tanzi F, Taglietti V, Magistretti J. Cu2+, Co2+, and Mn2+ modify the gating kinetics of high-voltage-activated Ca2+ channels in rat palaeocortical neurons. J Membr Biol. 2003;195(3):121–136. doi: 10.1007/s00232-003-0614-2. [DOI] [PubMed] [Google Scholar]
- 45.Hagiwara S, Byerly L. Calcium channel. Annu Rev Neurosci. 1981;4:69–125. doi: 10.1146/annurev.ne.04.030181.000441. [DOI] [PubMed] [Google Scholar]
- 46.Thevenod F, Jones SW. Cadmium block of calcium current in frog sympathetic neurons. Biophys J. 1992;63(1):162–168. doi: 10.1016/S0006-3495(92)81575-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Winegar BD, Kelly R, Lansman JB. Block of current through single calcium channels by Fe, Co, and Ni. Location of the transition metal binding site in the pore. J Gen Physiol. 1991;97(2):351–367. doi: 10.1085/jgp.97.2.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Gavva NR, Tamir R, Klionsky L, Norman MH, Louis JC, Wild KD, Treanor JJ. Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1. Mol Pharmacol. 2005;68(6):1524–1533. doi: 10.1124/mol.105.015727. [DOI] [PubMed] [Google Scholar]